Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Radial Reload Open LAR Case Series

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Covidien
Duke University
Providence Medical Research Center
University of South Florida
Information provided by (Responsible Party):
Covidien Identifier:
First received: October 26, 2012
Last updated: January 7, 2014
Last verified: January 2014

The purpose of this research study is to evaluate the safety and feasibility of the Radial Reload Stapler during open LAR for rectal cancer. The surgeon will complete questionnaires relating to the function of the device.

Condition Intervention
Low Anterior Resection
Proctosigmoid Resection
Rectal Cancer
Device: Covidien Radial Reload Stapler

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Open Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series

Resource links provided by NLM:

Further study details as provided by Covidien:

Primary Outcome Measures:
  • Staple Line [ Time Frame: Operative ] [ Designated as safety issue: No ]
    The surgeon's ability to achieve a staple line at the desired level of the rectum.

  • Distal Margins [ Time Frame: Operative ] [ Designated as safety issue: No ]
    The ability to achieve adequate distal margins (defined as >2cm [or >1cm with clear histologic evaluation]) in the low rectum.

Secondary Outcome Measures:
  • Usability [ Time Frame: Operatively ] [ Designated as safety issue: No ]
    1. Access measured by surgeon usability questionnaire.
    2. Visibility measured by surgeon usability questionnaire.
    3. Maneuverability measured by surgeon usability questionnaire.

Estimated Enrollment: 30
Study Start Date: May 2013
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Covidien Radial Reload Stapler Device: Covidien Radial Reload Stapler


Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. The subject is able to understand and sign Informed Consent Form.
  2. The subject is between 18-85 years of age.
  3. The subject is anticipated to undergo a resection of the rectum with anastomosis below the peritoneal reflection for the treatment of rectal cancer.
  4. The subject is anticipated to undergo mobilization and stapling of the rectum through an open incision.

Exclusion Criteria:

  1. Any female patient, who is pregnant, suspected pregnant, or nursing.
  2. The participant is unable or unwilling to comply with the study requirements, follow-up schedule.
  3. The participant has co-morbidities which, in the opinion of the investigator, will not be appropriate for the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01717014

Contact: Jessica Chowaniec 203-821-4741
Contact: Jessica Carlson 203-821-4734

United States, Florida
University of South Florida Recruiting
Tampa, Florida, United States, 33606
Contact: Shaun Crittenden    813-844-4069      
Principal Investigator: Sowsan H. Rasheid, MD         
United States, North Carolina
Duke University Recruiting
Durham, North Carolina, United States, 27705
Principal Investigator: Christopher Mantyh, MD         
United States, Washington
Providence Medical Center Recruiting
Spokane, Washington, United States, 99204
Contact: Joan Milton    509-474-4323      
Principal Investigator: M. Shane McNevin, MD         
Sponsors and Collaborators
Duke University
Providence Medical Research Center
University of South Florida
  More Information

No publications provided

Responsible Party: Covidien Identifier: NCT01717014     History of Changes
Other Study ID Numbers: COVLARO0286
Study First Received: October 26, 2012
Last Updated: January 7, 2014
Health Authority: United States: Food and Drug Administration

Keywords provided by Covidien:
rectal cancer

Additional relevant MeSH terms:
Rectal Neoplasms
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Site
Rectal Diseases processed this record on November 25, 2014